Hantavirus cases spark surge in pharma and biotech stocks — here’s why

The outbreak of Hantavirus on a cruise ship has led to a surge in biotech and pharmaceutical stocks due to reports of firms developing vaccines. This increase is a result of potential treatments being developed. The Hantavirus outbreak is driving investment in these sectors.